Stay updated on aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:48:44.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T11:20:35.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Added a Publications entry for the ADRISK trial publication (Annals of Oncology 2025) and a Study Results entry detailing 24-month outcomes. Removed Plan to Share IPD, Plan for IPD, and Product Manufactured in and Exported from the U.S. items.
    Difference
    0.9%
    Check dated 2026-02-18T04:08:00.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A new software revision label (Revision: v3.4.2) was added, and an older government funding notice (and Revision: v3.4.1) were removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:04:42.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A site-wide funding-status notice was added and the system revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:24:32.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The page adds a glossary display and new metadata items (Last Update Submitted that Met QC Criteria, No FEAR Act Data) along with the Revision: v3.4.0 tag. These updates affect navigation and auditing information but do not change the actual study details or results.
    Difference
    0.2%
    Check dated 2026-01-27T20:59:55.000Z thumbnail image

Stay in the know with updates to aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the aRCH With Cisplatin ± Pembrolizumab in HNSCC Clinical Trial page.